SCHEMBL2405006

SCHEMBL2405006

CC(C)N(NP(O)OCCC#N)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30824460 0.82
SCHEMBL1409240 0.82
SCHEMBL6231124 0.79
SCHEMBL23419456 0.77 TSHR (0.30)
SCHEMBL23117842 0.74
SCHEMBL13292084 0.74
SCHEMBL252367 0.73 TSHR (0.30)
SCHEMBL7262903 0.73 TSHR (0.30)
SCHEMBL7858703 0.73 TSHR (0.30)
Hydrochloric Acid SCHEMBL25380883 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165569-B1 BORONIC ACID CONTAINING REAGENTS AND OLIGONUCLEOTIDES AGILENT TECHNOLOGIES INC (US) 2005-08-10 EP claimed
EP-1165569-A1 BORONIC ACID CONTAINING REAGENTS AND OLIGONUCLEOTIDES Agilent Technologies, Inc. (US) 2002-01-02 EP claimed
WO-2000056740-A1 BORONIC ACID CONTAINING REAGENTS AND OLIGONUCLEOTIDES PROLINX, INC. (US) 2000-09-28 WO claimed
US-6031117-A Boronic acid containing phosphoramidite reagents PROLINX INCORPORATED (US) 2000-02-29 US claimed
US-5869644-A Synthesis of diverse and useful collections of oligonucleotidies THE JOHNS HOPKINS UNIVERSITY (US) 1999-02-09 US claimed
US-8026349-B2 Polynucleotide synthesis labeling chemistry DHARMACON, INC. (US) 2011-09-27 US disclosed
US-7687618-B2 reaction of an oligonucleotide having a labile protecting group bound to a terminal hydroxy group, and a labeling compound; nucleophilic substitution reaction; lower reaction times and yields are advantageous for the user because they permit a high throughput with low technical requirements NIMBLEGEN SYSTEMS GMBH (DE) 2010-03-30 US disclosed
WO-2009143369-A2 METHOD OF PREPARING NUCLEOSIDES AND ANALOGS THEREOF WITHOUT USING CHROMATOGRAPHY ISIS PHARMACEUTICALS, INC. (US) 2009-11-26 WO disclosed
EP-0638089-B2 SYNTHESIS OF DIVERSE AND USEFUL COLLECTIONS OF OLIGONUCLEOTIDES UNIV JOHNS HOPKINS (US) 2008-03-05 EP disclosed
US-20080009612-A1 Novel Polynucleotide Synthesis Labeling Chemistry DHARMACON, INC. 2008-01-10 US disclosed
EP-1788875-A2 NOVEL POLYNUCLEOTIDE SYNTHESIS LABELING CHEMISTRY Dharmacon, Inc. (US) 2007-05-30 EP disclosed
US-20060122382-A1 Method of manufacturing labelled oligonucleotide conjugates NIMBLEGENSYSTEMS GMBH (DE) 2006-06-08 US disclosed
US-5393878-A Pyrimidine nucleosides having cyclopentafuran skeleton CIBA-GEIGY CORPORATION (US) 1995-02-28 US disclosed
EP-0638089-A1 SYNTHESIS OF DIVERSE AND USEFUL COLLECTIONS OF OLIGONUCLEOTIDES THE JOHNS HOPKINS UNIVERSITY (US) 1995-02-15 EP disclosed
EP-0633890-A1 SUPPORT FOR OLIGONUCLEOTIDE SYNTHESIS ZENECA LIMITED (GB) 1995-01-18 EP disclosed
US-5319080-A Antiviral agents CIBA-GEIGY CORPORATION (US) 1994-06-07 US disclosed
WO-1993021203-A1 SYNTHESIS OF DIVERSE AND USEFUL COLLECTIONS OF OLIGONUCLEOTIDES THE JOHNS HOPKINS UNIVERSITY (US) 1993-10-28 WO disclosed
WO-1993020091-A1 SUPPORT FOR OLIGONUCLEOTIDE SYNTHESIS ZENECA LIMITED (GB) 1993-10-14 WO disclosed
EP-0451141-A1 IMMOBILIZED SEQUENCE-SPECIFIC PROBES F. HOFFMANN-LA ROCHE AG (CH) 1991-10-16 EP disclosed
WO-1989011548-A1 IMMOBILIZED SEQUENCE-SPECIFIC PROBES CETUS CORPORATION (US) 1989-11-30 WO disclosed